All Substitutes


Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
General Image 1
General Image 2
General Image 1
20% Off

RTU-Doce RTU 80mg Injection

Prescription Required

Salt Composition : Docetaxel

Manufacturer : ADLEY FORMULATIONS

Origin of Medicine : India

MRP: 13915
Price : 11132
You Save : 2783 (20%)

1 Vial(s) Of 4ml

Pincode
Delivery By -

Introduction to Rtu-doce Rtu 80mg Injection

RTU-Doce RTU 80mg Injection contains an active constituent of docetaxel, which belongs to the class of anticancer medications known as taxoids. It is a chemotherapy medication used to treat breast, prostate, non-small cell lung, stomach, and head and neck cancers. This chemotherapy medication is used alone or in combination with other anticancer medicines.  

 

Inform your doctor if you are allergic to RTU-Doce RTU 80mg Injection and its ingredients. Before taking this medication, you must inform your physician if you have kidney and heart problems, vision problems, epilepsy, or alcohol addiction. It is not recommended for individuals with very few white blood cells or severe liver diseases. Use effective birth control during the treatment and at least six months after the last dose of RTU-Doce RTU 80mg Injection. Additionally, tell your doctor if you have or recently had any vaccinations before starting this treatment. Always give a detailed account of your medical history and medications to your healthcare provider for the safe and effective use of RTU-Doce RTU 80mg Injection.


Uses of Rtu-doce Rtu 80mg Injection

  • Non-small cell lung cancer
  • Breast cancer
  • Stomach or gastric cancer
  • Prostate cancer
  • Head and neck cancer

Therapeutic Effects of Rtu-doce Rtu 80mg Injection

RTU-Doce RTU 80mg Injection works by binding to a protein called beta-tubulin, which helps cells grow and divide. By doing this, it stops cancer cells from dividing properly and prevents the formation of structures needed for cell division. Additionally, RTU-Doce RTU 80mg Injection reduces the activity of a gene called BCL2, which usually helps cancer cells survive. By lowering this gene's activity, the treatment helps cancer cells become more sensitive to natural cell death processes, making it easier for the body to fight against the cancer.


Interaction of Rtu-doce Rtu 80mg Injection with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with RTU-Doce RTU 80mg Injection and cause undesirable side effects.


More Information about Rtu-doce Rtu 80mg Injection

  • Keep RTU-Doce RTU 80mg Injection out of sight and reach of children.
  • Do not store above 25°C.
  • Do not use this medicine after the expiry date.

How to consume Rtu-doce Rtu 80mg Injection

A healthcare professional will administer it through an intravenous infusion directly into one of your veins. Your doctor will decide the suitable dose of RTU-Doce RTU 80mg injection for you based on your weight and overall health.


Safety Advices for Rtu-doce Rtu 80mg Injection

Image Not Available  

Pregnancy

  

It is unsafe to use during pregnancy as it may cause harmful effects on the unborn baby. Women of childbearing age should use effective contraceptives during treatment and six months after the final dose.

Image Not Available  

Breast Feeding

  

It is not recommended to breastfeed during the treatment with RTU-Doce RTU 80mg Injection and for one week after the last dose. Inform your doctor if you are breastfeeding before taking this medication.

Image Not Available  

Lungs

  

RTU-Doce RTU 80mg Injection is commonly prescribed as a first-line therapy for patients with non-small cell lung cancer. However, it may lead to pulmonary toxicity in some individuals a few weeks after treatment initiation. Therefore, it is crucial to inform your doctor about any pre-existing lung disorders before undergoing RTU-Doce RTU 80mg Injection treatment.

Image Not Available  

Liver

  

RTU-Doce RTU 80mg Injection is not recommended in patients with severe liver disorders. Inform your doctor if you have any liver disorder before taking this treatment. Your doctor may advise you to take blood tests to monitor your liver function before and during the treatment with RTU-Doce RTU 80mg Injection.

Image Not Available  

Alcohol

  

It is unsafe to consume alcohol while taking RTU-Doce RTU 80mg Injection, as RTU-Doce RTU 80mg Injection itself contains alcohol. Alcohol intake can enhance its effects, potentially leading to increased dizziness and drowsiness. Please consult your doctor for further guidance.

Image Not Available  

Driving

  

RTU-Doce RTU 80mg Injection contains alcohol, which affects your central nervous system and impairs your ability to drive or operate heavy machinery. Therefore, it is not recommended to drive or operate heavy machinery while undergoing treatment with this medication.


Side Effects of Rtu-doce Rtu 80mg Injection

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.


Serious:

  • Severe allergic reactions
  • Severe fluid retention
  • Severe skin problems
  • Swelling of the small intestine and colon


Common:

  • Headache, dizziness
  • Risk of infections
  • Low blood cell count
  • Loss of appetite
  • Trouble sleeping
  • Joint or muscle pain
  • Alteration in the sense of taste
  • Eye problems, bleeding from the nose
  • Nausea, vomiting
  • Diarrhea, constipation
  • Abdominal pain
  • Hair loss, change in color of your nails
  • Change or absence of menstrual period
  • Weight loss
  • Tiredness
  • Dry mouth
  • High blood sugar
  • Decreased blood pressure, rapid heartbeat

Word of Advice

Women of reproductive age must use effective contraception during and for six months after therapy. Male patients receiving this injection treatment should avoid fathering children and use reliable contraception for six months following the treatment. A decrease in white blood cell count is the most common side effect of RTU-Doce RTU 80mg Injection. 

 

If your white blood cell count becomes low, you are at a higher risk of getting an infection. However, these levels usually return to normal before your next treatment. A blood test will be conducted before your treatment. If your white blood cell count is low, your doctor may postpone your treatment for a short period until your cell count increases. You might receive a supportive drug to stimulate your body to produce more white blood cells. 

 

Following the RTU-Doce RTU 80mg Injection infusion, you will be carefully monitored for reactions and side effects. Supportive care will help you manage and overcome these side effects. On your chemotherapy day, it is recommended that you eat lightly. Consuming small portions slowly and regularly every few hours works best. Avoid skipping meals and stay away from fatty, greasy, or spicy foods on these days. Do not hesitate to ask questions or share any concerns with your doctor. 


FAQs

Q 1. Is RTU-Doce RTU 80mg Injection a strong chemotherapy drug?

Yes, RTU-Doce RTU 80mg Injection is a powerful chemotherapy medication because it contains the active ingredient Docetaxel, which is known to kill cancer cells with a rapid rate of growth.

Q 2. Can RTU-Doce RTU 80mg Injection treat prostate cancer?

RTU-Doce RTU 80mg Injection is a chemotherapy medication that may ease prostate cancer symptoms and help to treat prostate cancer.

Q 3. Who is contraindicated from taking RTU-Doce RTU 80mg Injection?

RTU-Doce RTU 80mg Injection should not be taken for severe liver disease, low white blood cell counts, or hypersensitivity reactions to RTU-Doce RTU 80mg Injection and its ingredients.

Q 4. Can I take vaccinations while taking RTU-Doce RTU 80mg Injection?

No, The live vaccine may interact with RTU-Doce RTU 80mg Injection. Hence, without consulting your healthcare provider, this medication should not be taken with any vaccinations.


Fact Box of Rtu-doce Rtu 80mg Injection

Molecule Name: Docetaxel

Therapeutic class: Chemotherapy drugs

 

Pharmacological class: Taxoids

Indications:  

1.  Non-small cell lung cancer

2.  Breast cancer

3.  Head and neck cancer

4.  Stomach cancer

5.  Prostate cancer 


References

  1. Seacross Pharma (Europe) Ltd, Electronic medicines compendium (EMC), [Revised on May 2022] [Accessed on Oct 2023], https://www.medicines.org.uk/emc/files/pil.7206.pdf
  2. Sanofi-aventis US LLC, US Food and Drug Administration (FDA), [Revised on May 2020] [Accessed on Oct 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020449s084lbl.pdf
  3. Angela M Davies et al. Docetaxel in non-small cell lung cancer: a review; Expert Opinion on Pharmacotherapy; Published on April 2003; Accessed on 26/10/2023; https://pubmed.ncbi.nlm.nih.gov/12667118/
  4. Katherine A Lyseng-Williamson, Caroline Fenton; Docetaxel: a review of its use in metastatic breast cancer; Drugs; Published on 2005; Accessed on 26/10/2023; https://pubmed.ncbi.nlm.nih.gov/16296875/
  5. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1707 - 1709.
  6. KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 866.

Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that experts, accurate and trustworthy, review. The information and contents of this website are for informational purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Please seek your doctor's advice and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.